Oberweis Asset Management »

Adaptive Biotechnologies Cor shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 727k 14.96
2025-06-30 $6.9M 589k 11.65

More positions owned by Oberweis Asset Management

Credo Technology Group Holding (CRDO)
Lumentum Hldgs (LITE)
Rambus (RMBS)
Ambarella (AMBA)
Sharkninja (SN)
Applied Optoelectronics (AAOI)
Encompass Health Corp (EHC)
Frontdoor (FTDR)
Adma Biologics (ADMA)
American Superconductor (AMSC)
Sportradar Group Ag Class A Ord (SRAD)
NOVA MEASURING Instruments L (NVMI)
Itron (ITRI)
SkyWest (SKYW)
Sitime Corp (SITM)

View all positions for Oberweis Asset Management

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Ameriprise Financial
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
ARK Investment Management
Aristotle Atlantic Partners
State Street Corporation
Driehaus Capital Management
Fred Alger Management
Arrowstreet Capital, Limited Partnership
Blue Water Life Science Advisors
Macquarie Group

View all funds holding Adaptive Biotechnologies Cor